title: Two novel missense mutations in the myelin protein zero gene causes Charcot-Marie-Tooth type 2 and Déjérine-Sottas syndrome.
abstract: BACKGROUND
  The Charcot-Marie-Tooth (CMT) phenotype caused by mutation in the myelin protein zero (MPZ) gene varies considerably, from early onset and severe forms to late onset and milder forms. The mechanism is not well understood. The myelin protein zero (P0) mediates adhesion in the spiral wraps of the Schwann cell's myelin sheath. The crystalline structure of the extracellular domain of the myelin protein zero (P0ex) is known, while the transmembrane and intracellular structure is unknown.
  
  
  RESULTS
  One novel missense mutation caused a milder late onset CMT type 2, while the second missense mutation caused a severe early onset phenotype compatible with Déjérine-Sottas syndrome.
  
  
  CONCLUSIONS
  The phenotypic variation caused by different missense mutations in the MPZ gene is likely caused by different conformational changes of the MPZ protein which affects the functional tetramers. Severe changes of the MPZ protein cause dysfunctional tetramers and predominantly uncompacted myelin, i.e. the severe phenotypes congenital hypomyelinating neuropathy and Déjérine-Sottas syndrome, while milder changes cause the phenotypes CMT type 1 and 2.
authors.affiliation: Faculty Division Akershus University Hospital, University of Oslo, 1474 Nordbyhagen, Oslo, Norway. g.j.braathen@medisin.uio.no.
authors.forename: Geir J
authors.initials: GJ
authors.lastname: Braathen
authors.forename: Jette C
authors.initials: JC
authors.lastname: Sand
authors.forename: Michael B
authors.initials: MB
authors.lastname: Russell
references.citation: J Neurosci. 2006 Feb 22;26(8):2358-68
references.pmid: 16495463
references.citation: Cell. 1985 Mar;40(3):501-8
references.pmid: 2578885
references.citation: Neurology. 2004 Jun 8;62(11):2122-3
references.pmid: 15184631
references.citation: Brain. 1999 Feb;122 ( Pt 2):281-90
references.pmid: 10071056
references.citation: Cell. 1996 Nov 1;87(3):543-52
references.pmid: 8898206
references.citation: Nat Genet. 1997 Jan;15(1):62-9
references.pmid: 8988170
references.citation: Can J Neurol Sci. 2002 Aug;29(3):258-66
references.pmid: 12195616
references.citation: Clin Genet. 1974;6(2):98-118
references.pmid: 4430158
references.citation: J Neurosci Res. 2000 Jun 15;60(6):714-24
references.pmid: 10861783
references.citation: Nat Genet. 1993 Sep;5(1):35-9
references.pmid: 7693130
references.citation: Neuron. 1990 Mar;4(3):449-60
references.pmid: 1690568
references.citation: J Neurol Neurosurg Psychiatry. 1999 Aug;67(2):174-9
references.pmid: 10406984
references.citation: Brain. 2003 Jan;126(Pt 1):134-51
references.pmid: 12477701
references.citation: J Cell Biol. 2005 Sep 26;170(7):1067-78
references.pmid: 16172208
references.citation: Neuron. 1996 Sep;17(3):435-49
references.pmid: 8816707
references.citation: Hum Mutat. 1998;Suppl 1:S217-9
references.pmid: 9452091
references.citation: Neurology. 2005 Apr 12;64(7):1209-14
references.pmid: 15824348
references.citation: Ann Neurol. 2002 Feb;51(2):190-201
references.pmid: 11835375
references.citation: Neuron. 1988 Sep;1(7):535-43
references.pmid: 2483101
references.citation: J Neurol Neurosurg Psychiatry. 1999 Jun;66(6):779-82
references.pmid: 10329755
references.citation: Nature. 1990 Apr 26;344(6269):871-2
references.pmid: 1691824
references.citation: Brain. 2004 Feb;127(Pt 2):371-84
references.pmid: 14711881
references.citation: Neurochem Res. 1996 Apr;21(4):527-35
references.pmid: 8734447
references.citation: J Neurol. 1999 Jul;246(7):596-9
references.pmid: 10463363
references.citation: Neuron. 2008 Feb 7;57(3):393-405
references.pmid: 18255032
references.citation: Lancet Neurol. 2002 Jun;1(2):110-8
references.pmid: 12849515
references.citation: Hum Mol Genet. 2008 Jul 1;17(13):1877-89
references.pmid: 18337304